Support from a nurse for patients with head and neck cancer
Impact in Head and Neck Oncology of Support by a Nurse in the Patient's Care Pathway.
University Hospital, Toulouse · NCT06203808
This study is testing whether support from a nurse can help newly diagnosed patients with head and neck cancer feel better and manage their treatment more effectively compared to standard care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 320 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Toulouse (other) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT06203808 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the impact of nurse-led health coaching on newly diagnosed patients with head and neck cancer. Conducted over 12 months at University Hospital in Toulouse, it compares two groups: one receiving coaching support for treatment coordination and rehabilitation services, and a control group receiving standard care without coaching. Both groups will complete quality of life questionnaires at multiple time points to assess the effectiveness of the coaching intervention. The study aims to address healthcare disparities and improve patient outcomes in this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates are newly diagnosed patients with head and neck squamous cell carcinoma who are eligible for curative treatment.
Not a fit: Patients with a history of previous cervical surgery, head and neck irradiation, or other significant uncontrolled medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance the quality of life and treatment experience for patients with head and neck cancer.
How similar studies have performed: While health coaching has shown effectiveness in other medical fields, its application in head and neck cancer care is limited, making this approach relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Patient with a histologically proven diagnosis of head and neck squamous cell carcinoma (HNSCC) of the upper aerodigestive tract * Patient whose disease is classified UICC (Union for International Cancer Control (UICC) Tumour, Node, Metastasis (TNM) stage (8th edition): T0-4a NO/N3 M0 (no distant metastasis M0) * Patient World Health Organization (WHO) 0-1-2 * Treatment with a feasible curative aim (no contraindication to optimal treatment such as surgery or chemotherapy at a curative dose) * Patient affiliated to a Social Security scheme in France * Patient who did not object to participating in the research. Non-inclusion criteria: * Patient with a history of previous cervical surgery and/or head and neck irradiation * Pregnant or breastfeeding women * Patient suffering from another co-existing malignant disease at the time of inclusion or any other significant medical (immunosuppression etc.), psychiatric or surgical condition, currently not controlled by treatment, which may interfere with the achievement of the study. * Any psychological, family, geographic or sociological condition that does not allow compliance with medical monitoring and/or the procedures provided for in the study protocol. * Patients deprived of liberty or under legal protection regime (curatorship and guardianship, safeguard of justice).
Where this trial is running
Toulouse
- Chu de Toulouse — Toulouse, France (RECRUITING)
Study contacts
- Principal investigator: AGNES DUPRET-BORIES — University Hospital, Toulouse
- Study coordinator: AGNES DUPRET-BORIES
- Email: dupretbories.a@chu-toulouse.fr
- Phone: (0)5 31 15 60 14
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Head and Neck Cancer